Cover image not available

Costing statement : rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults

National Institute for Health and Clinical Excellence

Publication Data

Title Costing statement : rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults
Alternative Title Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults
Author National Institute for Health and Clinical Excellence
Publisher National Institute of Health and Clinical Excellence
Publication date 2010
Publication location London
Language English

Topics

Thrombophlebitis :: Chemotherapy :: Cost effectiveness
Anticonvulsants
Total hip replacement :: Complications
England

Catalogue Data

OBNB ID GBB586549
ISBN 10 n/a
ISBN 13 n/a
Type BibliographicResource, Book
Dewey Classification 616.142061

ISBD

P1053 1 online resource (3 pages)
P1042 Includes bibliographical references.

Buy a copy

OBNB doesn't sell books, but you may be able to find a copy at one of these websites:

Costing statement : rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults by National Institute for Health and Clinical Excellence. Published by National Institute of Health and Clinical Excellence in 2010. Publication and catalogue information, links to buy online and reader comments.